| Issue Date | Title | Author(s) |
| 2015-10-06 | Differential targeting of the cyclin-dependent kinase inhibitor, p21(CIP1/WAF1), by chelators with anti-proliferative activity in a range of tumor cell-types | Moussa, RS; Kovacevic, Z; Richardson, DR |
| 2021-10 | LL-37 and HMGB1 induce alveolar damage and reduce lung tissue regeneration via RAGE. | Pouwels, SD; Hesse, L; Wu, X; Allam, VSRR; van Oldeniel, D; Bhiekharie, LJ; Phipps, S; Oliver, BG; Gosens, R; Sukkar, MB; Heijink, IH |
| 2018-03 | Transcriptional regulation of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by the chelator, Dp44mT. | Moussa, RS; Kovacevic, Z; Bae, D-H; Lane, DJR; Richardson, DR |
| 2021 | Perfluorocarbons Therapeutics in Modern Cancer Nanotechnology for Hypoxiainduced Anti-tumor Therapy. | Satija, S; Sharma, P; Kaur, H; Dhanjal, DS; Chopra, RS; Khurana, N; Vyas, M; Sharma, N; Tambuwala, MM; Bakshi, HA; Charbe, NB; Zacconi, FC; Chellappan, DK; Dua, K; Mehta, M |
| 2021-01-01 | A potential MRI agent and an anticancer drug encapsulated within CPMV virus-like particles. | Aljabali, AAA; Alzoubi, L; Hamzat, Y; Alqudah, A; Obeid, MA; Al Zoubi, MS; Ennab, RM; Alshaer, W; Albatayneh, K; Al-Trad, B; Alqudah, DA; Chellappan, DK; Gupta, G; Tambuwala, MM; Kamal, D; Evans, DJ |
| 2022-01 | Histone deacetylase inhibitor 2-hexyl-4-pentynoic acid enhances hydroxyurea therapeutic effect in triple-negative breast cancer cells. | Ding, C; Su, B; Li, Q; Ding, W; Liu, G; Cai, Z; Zhang, F; Lim, D; Feng, Z |
| 2023-02-13 | VPA mediates bidirectional regulation of cell cycle progression through the PPP2R2A-Chk1 signaling axis in response to HU. | Su, B; Lim, D; Qi, C; Zhang, Z; Wang, J; Zhang, F; Dong, C; Feng, Z |
| 2017-01-01 | Calcium-calpain dependent pathways regulate vesiculation in malignant breast cells | Taylor, J; Jaiswal, R; Bebawy, M |
| 2019-08-15 | Recent update on anti-dengue drug discovery | Dighe, SN; Ekwudu, O; Dua, K; Chellappan, DK; Katavic, PL; Collet, TA |
